Three-season effectiveness of inactivated influenza vaccine in preventing influenza illness and hospitalization in children in Japan, 2013-2016.

ABSTRACT

OBJECTIVES: We assessed the vaccine effectiveness (VE) of inactivated influenza vaccine (IIV) in children 6 months to 15 years of age in 2015/16 season. In addition, based on the data obtained during the three seasons from 2013 to 2016, we estimated the three-season VE in preventing influenza illness and hospitalization. METHODS: Our study was conducted according to a test-negative case-control design (TNCC) and as a case-control study based on influenza rapid diagnostic test results. RESULTS: During 2015/16 season, the quadrivalent IIV was first used in Japan. The adjusted VE in preventing influenza illness was 49% (95% confidence interval [CI] 42-55%) against any type of influenza, 57% (95% CI 50-63%) against influenza A and 34% (95% CI 23-44%) against influenza B. The 3-season adjusted VE was 45% (95% CI 41-49%) against influenza virus infection overall (N = 12,888), 51% (95% CI 47-55%) against influenza A (N = 10,410), and 32% (95% CI 24-38%) against influenza B (N = 9232). An analysis by age groups showed low or no significant VE in infants or adolescents. By contrast, VE was highest in the young group (1-5 years old) and declined with age thereafter. The 3-season adjusted VE in preventing hospitalization as determined in a case-control study was 52% (95% CI 42-60%) for influenza A and 28% (95% CI 4-46%) for influenza B, and by TNCC design, it was 54% (95% CI 41-65%) for influenza A and 34% (95% CI 6-54%) for influenza B. CONCLUSION: We demonstrated not only VE in preventing illness, but also VE in preventing hospitalization based on much larger numbers of children than previous studies.